Choumane Nermine S, Malaeb Diana N, Malaeb Bassem, Hallit Souheil
Lebanese International University, School of Pharmacy, Beirut, Lebanon.
American University of Beirut Medical Center, Beirut, Lebanon.
BMC Health Serv Res. 2018 Feb 1;18(1):80. doi: 10.1186/s12913-018-2874-7.
Health care professionals (HCP) are known key elements of effective patient's counselling and education. For patients taking warfarin, education about the dose, side effects, and toxicity is clearly identified as a cornerstone of achieving improved health and quality of life. The study objective was to evaluate the patients' knowledge about warfarin and assess the impact of the health care professionals' counselling in enhancing patients' knowledge in achieving warfarin therapeutic outcomes.
A six-month prospective multicentered study was conducted in three hospitals, enrolling 300 patients admitted to the cardiac care unit and internal medicine departments. Patients' warfarin knowledge and INR levels were assessed before and after the clinical pharmacist counselling. The main therapeutic outcome was the impact of the clinical pharmacist-physician counselling on improving patient's education and achieving therapeutic INR level.
A higher mean knowledge about warfarin score was found after counselling as compared to before counselling (4.82 vs 13.2; p < 0.001). Likewise, the drug dose (1.05 vs 1.88), drug toxicity (0.41 vs 1.92), drug-drug and food-drug interactions (0.02 vs 1.89), therapeutic INR and general drug knowledge scores (2.66 vs 4.68) were significantly higher after as compared to before counselling (p < 0.001 for all variables). The percentages of patients who achieved therapeutic INR levels pre/post counselling was 37.2% and 74.4% respectively (p < 0.001).
Based on the study findings, HCP play a major role in enhancing patients' knowledge about the factors that affect warfarin therapeutic outcomes. This study highlights the need to establish and develop strategies for appropriate warfarin utilization in Lebanon.
医疗保健专业人员(HCP)是有效患者咨询和教育的关键要素。对于服用华法林的患者,关于剂量、副作用和毒性的教育被明确视为改善健康和生活质量的基石。本研究的目的是评估患者对华法林的了解,并评估医疗保健专业人员的咨询对增强患者知识以实现华法林治疗效果的影响。
在三家医院进行了一项为期六个月的前瞻性多中心研究,招募了300名入住心脏监护病房和内科的患者。在临床药剂师咨询前后评估患者的华法林知识和国际标准化比值(INR)水平。主要治疗结果是临床药剂师 - 医生咨询对改善患者教育和实现治疗性INR水平的影响。
与咨询前相比,咨询后发现对华法林的平均知识得分更高(4.82对13.2;p < 0.001)。同样,药物剂量(1.05对1.88)、药物毒性(0.41对1.92)、药物相互作用和食物 - 药物相互作用(0.02对1.89)、治疗性INR和一般药物知识得分(2.66对4.68)在咨询后均显著高于咨询前(所有变量p < 0.001)。咨询前/后达到治疗性INR水平的患者百分比分别为37.2%和74.4%(p < 0.001)。
基于研究结果,医疗保健专业人员在增强患者对影响华法林治疗效果因素的了解方面发挥着重要作用。本研究强调了在黎巴嫩建立和制定适当使用华法林策略的必要性。